简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Nukkleus培育Nukkleus防御技术,作为其以国防为中心的活动的基石;公司与Bladeranger Ltd签订了一项独家美国分销协议;根据协议条款,Nukkleus将为Blade Range解决方案在美国的独家分销权提供前期许可付款

2025-08-26 23:14

NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Nukkleus Inc. (NASDAQ: NUKK) ("Nukkleus" or the "Company"), a strategic acquirer and developer of high-growth businesses in the Aerospace and Defense (A&D) industry, today

NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Nukkleus Inc. (NASDAQ:NUKK) ("Nukkleus" or the "Company"), a strategic acquirer and developer of high-growth businesses in the Aerospace and Defense (A&D) industry, today announced the establishment of Nukkleus Defense Technologies Inc. ("Nukkleus Defense Technologies"), a wholly owned subsidiary that will serve as the cornerstone of its defense-focused activities. In parallel, the Company has entered into an exclusive US distribution agreement with BladeRanger Ltd. (TASE: BLRN) ("BladeRanger"), a publicly traded Israeli innovator in advanced drone payload systems for defense, homeland security, and solar applications.

Nukkleus Defense Technologies Subsidiary

The establishment of Nukkleus Defense Technologies subsidiary marks a significant step in the Company's broader strategy of acquiring and developing high-growth businesses within the A&D industry. Following the previously announced agreement with Star 26 Capital Inc., which remains subject to shareholder approval, the subsidiary will serve as the foundation for Nukkleus' defense-focused activities, initially through the commercialization of advanced third-party solutions and, over time, through the development of proprietary technologies designed to meet the growing global demand for next-generation defense capabilities.

Agreement with BladeRanger

As part of this strategic pivot, Nukkleus has entered into an exclusive three-year distribution agreement with BladeRanger, with the option to extend for an additional five years, subject to performance. The agreement grants Nukkleus the sole rights to bring BladeRanger's proprietary drone payload technologies to the U.S. market.

BladeRanger's advanced payload system solutions are designed to enhance surveillance, reconnaissance, tactical operations, and critical infrastructure maintenance for homeland security, and industrial applications. The partnership aims to accelerate adoption of BladeRanger's advanced payload systems across U.S. defense and commercial markets.

The global drone payload market was valued at approximately $7.2 billion in 2020 and is expected to reach $33.3 billion by 2030, reflecting strong compound annual growth. This explosive trajectory underscores the urgency and opportunity of deploying advanced payload technologies at scale across defense and critical infrastructure sectors. 

Under the terms of the agreement, Nukkleus will provide an upfront licensing payment, for the exclusive distribution rights of Blade Range's solutions in the U.S. In addition, the Company has committed to minimum annual purchase volumes that will increase progressively over the three-year term. Should these commitments be met, the partnership will continue for an additional five years with higher purchase thresholds. The agreement also allows Nukkleus to establish subsidiary operations and engage sub-distributors to maximize market reach, while incorporating performance incentives such as annual purchase credits for exceeding sales targets.

"Our expansion into defense reflects both the evolving global security landscape and the opportunities we see in advanced drone technologies," said Menny Shalom, CEO of Nukkleus. "By establishing Nukkleus Defense Technologies and securing this exclusive partnership with BladeRanger, we are positioning ourselves to deliver transformative solutions to U.S. defense and homeland security customers while driving long-term value for our shareholders."

"This agreement provides BladeRanger with a direct pathway into the U.S. defense market through a strong and strategically aligned partner," said Hagai Klimor, CEO of BladeRanger. "Nukkleus' commitment to defense and their operational capabilities make them the ideal choice to scale our technologies in the United States."

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。